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CHAPTER I 
INTRODUCTION 
The biosynthesis of monoterpenes in higher plants and cholesterol 
in mammalian and avian tissues have been the subject of a large number 
of investigations. These investigations have involved a variety of 
precursors including C0 2 , acetate, mevalonate and geranylpyrophosphate. 
In all studies involving mammalian cholesterol synthesis the major 
control enzyme was found to be microsomal HMG-CoA reductase. 
Monoterpene biosynthesis in higher plants is believed to occur at 
two sites. The sites are believed to be: 1) the chloroplastic site 
which is involved in the production of chloroplasts pigments, and 
2) an extra-chloroplastic site for the biosynthesis of essential oils. 
It is also postulated that the HMG-CoA reductase may be associated 
with other enzymes of monoterpene biosynthesis. Since HMG-CoA reductase 
control in plant tissue has not been studied, the following objectives 
were undertaken: 1) to establish that there is HMG-CoA reductase 
activity in N. cataria, 2) to determine the intracellular location, 
3) to observe the properties of the enzymes involved in mevalonate 
metabolism and their relationship to HMG-CoA reductase, 4) to study the 
enzymes involved in mevalonate metabolism in cell-free extracts from 
a variety of sources for comparison with those from leaf tissue, and 
5) to determine if HMG-CoA reductase and the mevalonate activating 
enzymes might be associated in some way. 
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CHAPTER II 
LITERATURE REVIEW 
A. Cholesterol and Terpenoid Biosynthesis 
The first evidence that intact animals are capable of the de novo 
synthesis of cholesterol was provided by Schoenheimer and Breusch in 
1933. This finding was later confirmed in 1937 with the observation 
that deuterated water was rapidly incorporated into cholesterol in 
rats (1) •. In 1942 Block and Rittenberg showed that the two carbon 
compound, acetate, represented the major carbon source for cholesterol 
biosynthesis in animal tissues (2). Several studies, both in vitro and 
in vivo, have demonstrated that the major site of cholesterol synthesis 
in higher animals is in the liver. Srere, Popjak and others have shown 
that every tissue in the body is probably capable of synthesizing 
cholesterol from labelled acetate (1). 
The work of Block, Lynen, Cornforth, and Popjak led to the eluci-
dation of the biosynthetic pathway of cholesterol from acetate (3). 
The first steps of terpenoid synthesis in plants appears to be 
the same as those of cholesterol in animals (4, 5). The first step 
of the pathway is considered to be the conversion of S-hydroxy-S-
methylglutaryl coenzyme A to mevalonate. Mevalonate is phosphorylated 
to 5-phosphomevalonate, 5-phosphomevalonate is phosphorylated to 5-
pyrophosphomevalonate, and 5-pyrophosphomevalonate is decarboxylated 
2 
to isopentenyl pyrophosphate. An isomerization, with loss of 4-S 3 H 
from mevalonate (2-R3 H of isopentenyl pyrophosphate), is observed in 
the formation of dimethylallyl pyrophosphate. A simple head to tail 
condensation of isopentenyl pyrophosphate and dimethylallyl pyrophos-
phate results in the formation of the simple acyclic monoterpene 
pyrophosphate. 
Various reports of the chemical synthesis and stability of the 
intermediates of cholesterol and terpenoid synthesis are available 
and the interested reader is referred to these sources for further 
information (2, 6, 7, 8, 9, 10). 
B. Regulation of Cholesterol and 
Terpenoid Biosynthesis 
There is abundant evidence that the rate of cholesterol biosyn-
thesis in animals is regulated principally by three physiological 
variables: the amount of cholesterol in the diet; the caloric intake 
of the animal; and the functional integrity of the enterohepatic 
circulation of bile acids. 
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Gould and Popjak (11) and later Bucher et al., (12) were the first 
to show that cholesterol feeding causes a more marked inhibition in the 
conversion of acetate- 14C to cholesterol than was observed when labelled 
mevalonate was the sterol precursor. These results implied that regu-
lation occurred before mevalonate formation. This phenomenon was 
studied further by Siperstein and Guest (13), who demonstrated that 
liver slices from animals on a high cholesterol diet could incorporate 
acetate- 14C into carbon dioxide, fatty acids and ketone bodies even 
though cholesterol synthesis was almost completely suppressed. 
Siperstein and Fagen (14) developed a gas-liquid chromatographic pro-
cedure for measurement of the key intermediates in cholesterol 
biosynthesis. Their studies showed that the incorporation of acetate-
14C into mevalonate was inhibited markedly by cholesterol feeding, 
whereas incorporation of this precursor into S-hydroxy-S-methylgluta-
rate was virtually unaffected (15). 
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Siperstein and Guest (13) demonstrated that rats kept on a pro-
longed cholesterol diet diminished the enzyme activity at other steps 
in cholesterol synthesis in liver tissue. Thus, whereas the rate-
limiting step was still the reduction of B-hydroxy-B-methylglutaryl-
CoA, marked reduction of enzymatic activity distal to mevalonate was 
clearly demonstrable. This depression of enzymatic activity is almost 
certainly secondary to primary feedback inhibition of S-hydroxy-B-
methylglutary-CoA reductase during cholesterol feeding and probably 
has no direct role as a control mechanism of overall sterol synthesis 
by liver in the intact animal (Figure 1. A). 
It has also been shown that high plasma levels of endogenous 
cholesterol in the form of very low density lipoprotein derived from 
the liver do not cause an inhibition of hepatic cholesterol synthesis 
(16). Conversely, hepatic cholesterogenesis is very promptly inhibited 
when chylomicra are infused into the systemic circulation and greatly 
stimulated when chylomicra are removed by drainage of lymph cholesterol 
through a thoracic duct fistula (17). These data suggest that exo-
genous cholesterol absorbed through the intestine, but not endogenous 
cholesterol is responsible for the activation of the cholesterol 
feedback system. This also strongly implies that it is not cholesterol 
itself, but rather a lipoprotein form of cholesterol, which probably 
Figure 1. Enzymes of Cholesterol and Terpenoid Biosynthesis 
A. HMG-CoA Reductase 
B. Mevalonate Kinase 
C. 5-Phosphomevalonate Kinase 
D. 5-Pyrophosphomevalonate Decarboxylase 
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represents the actual feedback inhibitor of mevalonate synthesis and 
hence of cholesterol production. The question whether the cholesterol 
feedback system operates by direct end-product inhibition or by regu-
lation of enzyme synthesis by means of enzyme repression remains to be 
answered. Suggestive evidence that this control mechanism involves 
end-product inhibition is provided by the finding that a significant 
depression of cholesterol synthesis is observed within 2.5 hours after 
the intravenous injection of cholesterol containing chylomicra (16), 
whereas the turnover of HMG-CoA reductase in the liver appears to be 
much slower (1). A number of attempts to demonstrate an inhibition of 
either cholesterol or of mevalonate synthesis by the addition of 
cholesterol in vitro, in its free or esterfied forms (1, 3, 18), have 
been unsuccessful. 
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While almost all tissues have the ability to synthesize choles-
terol, only the liver demonstrates significant feedback inhibition of 
cholesterogenesis (19). In vitro studies have clearly shown that, next 
to liver, the intestine has the greatest cholesterogenic capacity of 
any body tissue. Normally, liver is the major source of plasma 
cholesterol, however, the intestine does make some contribution to the 
circulating cholesterol pool. Since the intestine shows little 
decrease in cholesterol synthesis in response to exogenous cholesterol, 
when a high cholesterol diet is fed, the intestine, rather than the 
liver, becomes the major source of endogenous plasma cholesterol. 
The lack of response to exogenous cholesterol in the intestine 
led investigators to look for another type of metabolic control. 
Dietschy and Wilson (3) and Siperstein (1) reported in review articles 
that the external diversion of bile flow leads to a rapid increase in 
8 
the rate of cholesterogenesis in the small intestine and the liver. 
Biliary diversion for 48 hours enhances cholesterol synthesis in the 
liver two to three times and in the small bowel by as much as 10 times. 
Bile contains a number of substances, including bile acids, 
cholesterol and phospholipids, that undergo an enterohepatic circula-
tion. Evidence from Siperstein (20) indicates that bile acid is the 
inhibitory component. 
Starvation, as well as chronic undernutrition, cause a definite 
depression in hepatic cholesterol synthesis. This effect is not the 
result of the absence of a specific dietary requirement since refeeding 
with any source of calories, fat, carbohydrate, or protein, will 
promptly restore cholesterogenesis to normal (1). 
The existence of the diurnal rhythm in HMG-CoA reductase was first 
reported for mouse liver (21) and shortly thereafter for rat liver (22, 
23), rat intestine (24) and certain rat and mouse hepatomas (25). 
Rhythmic variations in reductase activity in other species, particular-
ly in humans, or in other tissues has not yet been established. 
The only other enzyme in the cholesterol metabolic pathway that is 
known to have a diurnal rhythm is cholesterol 7-S-hydroxylase. This 
enzyme catalyzes the first reaction in the catabolism of cholesterol to 
bile acids (26). 
Hormones have also been implicated both in the maintenance of 
diurnal rhythm in reductase synthesis and in the overall regulation of 
cholesterol synthesis (27). Hormones believed to be involved in this 
regulatory process include insulin, glucagon, thyroid hormone and hydro-
cortisone. Evidence indicates that insulin and thyroid hormone may 
participate in the chain of events that initiate and maintain the 
increased rate of reductase synthesis that characterizes the rising 
portion of the rhythm (28, 29, 30), while hydrocortisone and glucagon, 
possibly via c.AMP, may be involved in the chain of events that termin-
ate reductase synthesis. 
Other hormones that stimulate reductase activity and cholestero-
genesis are epinephrine and norepinephrine (31). The steroid sex 
hormones, estrogens, progestins and androgens, can suppress reductase 
activity (32). However, it is not clear whether these hormones are 
acting as hormones or as cholesterol analogs. 
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Rates of cholesterol synthesis and HMG-CoA reductase activities 
are extremely variable, but frequently are elevated in primary and 
transplantable hepatomas. Partial or complete loss of regulation of 
cholesterol synthesis and of reductase activity by dietary cholesterol 
appears to be the only consistent feature of all hepatomas studied (1, 
27, 32). This defect may be associated with the onset of malignancy, 
since similar losses of regulation occur in livers of all hepatocarcin-
ogen-trea ted rats (27, 33, 34). 
The nature of the apparent defect in the regulation by dietary 
cholesterol is not clear. Other aspects of the regulation of choles-
terogenesis, such as the diurnal rhythm and suppression by fasting, are 
not lost (25, 27, 35). A consistent finding in all malignant tissue is 
reduced accumulation of cholesterol as cholesteryl esters after 
cholesterol feeding (17, 26, 37). This change may in some way be 
responsible for the abnormal regulation of reductase activity and 
cholesterol synthesis in these tissues. 
Review articles by Siperstein (1), Dietschy and Wilson (3) and 
Rodwell et al., (27) cover the literature on the regulation of 
cholesterol synthesis and HMG-CoA reductase very thoroughly. The 
reader is referred to the above reviews for further information on 
cholesterogenesis other than those covered in this review. 
The regulation of terpenoid synthesis in plants has not been 
studied. The control enzyme in mammalian system, HMG-CoA reductase, 
only recently has been reported in higher plants (38). No work has 
been done on the regulation of this enzyme in higher plants. Thus 
this part of the review was to present as concisely as possible the 
status of HMG-CoA reductase as a biological control point. 
C. Enzymes of Cholesterol and 
Terpenoid Biosynthesis 
1. HMG-CoA Reductase 
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HMG-CoA reductase (Mevalonate:NADP oxidoreductase [acylating CoA], 
EC 1.1.1.34) catalyzes the reduction by NADPH of -S-hydroxy-S-methyl-
glutaryl-coenzyme A to mevalonate. The enzyme has been partially 
isolated from a variety of sources including mannnalian and avian liver, 
yeast and plant (38, 39). It has been detected in the soluble and 
microsomal fractions and is believed to be the major site of control of 
cholesterol biosynthesis (39). 
The intracellular location of cholesterol feedback control has 
likewise been the subject of several studies which has been reviewed by 
Siperstein (1). Both microsomes and cytosol are required for the 
overall conversion of acetate to cholesterol; however, if one uses 
labelled -S-hydroxy-S-methylglutatyl-CoA as substrate, the reduction 
of this compound can be observed in the hepatic microsome (1). Other 
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studies indicated that over 90% of mevalonate production occurs in the 
microsomes, the remaining activity being in the cytosol (15). The 
microsomal enzyme is the major target of feedback inhibition of meval-
onate synthesis. The residual mevalonate synthesis of the cytosol is 
relatively unaffected by short term cholesterol feeding. The sub-
cellular localization of -B-hydroxy-S-methylglutaryl CoA reductase, and 
hence for cholesterol feedback control, can be carried further by 
subfractionating the microsome into its ribosomes, endoplasmic reticu-
lum and soluble interior. Assay of these fractions indicates that the 
reductase enzyme is localized exclusively in the lipoprotein that makes 
up the endoplasmic reticulum or membrane of the microsome (15). The 
entire lipid component of this enzyme is apparently not necessary for 
activity since Linn (18) has reported that an acetone powder of whole 
liver microsomes will reduce -S-hydroxy-B-methylglutaryl CoA to meval-
onate. 
In contrast to hepatic tissue, yeast HMG-CoA reductase is located 
in the mitochondria instead of the endoplasmic reticulum (40, 41). 
HMG-CoA reductase has only recently been reported in higher plants. 
Suzuki et al. (38), presented the first evidence for the occurrence of 
HMG-CoA reductase in sweet potato roots. It was found to be in both 
the mitochondrial and microsomal fractions. The Km for HMG-CoA was 
reported between 6.5 µM to 21 µM. 
It has been established that HMG-CoA reductase is tightly bound to 
microsomal membranes in hepatic cells (42). Shefer et al. (24) noted 
that the enzyme was located in both the mitochondrial and microsomal 
fractions of rat intestinal crypt cells. However, the enzyme is 
associated with the mitochondrial fraction in Saccharomyces cerevisiae 
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(43) and occurs in a soluble form in Tetrahymena pyriformis (44). The 
difference in the subcellular distribution of HMG-CoA reductase among 
various living organisms may provide information of physiological and 
evolutionary significance. For further information concerning the 
properties of HMG-CoA reductase the reader is referred to a detailed 
review by Rodwell, McNamara and Shapiro (27). 
2. Mevalonate Kinase 
The enzyme system that converts mevalonate to isopentenyl pyro-
phosphate is usually found mainly in the 100,000 x g for one hour of 
supernatant of most tissue homogenates (45, 46). In higher plants some 
of the enzymes involved in the synthesis of isopentenyl pyrophosphate 
have been found in chloroplasts (47, 38). 
Mevalonate kinase (ATP:mevalonate 5-phosphotransferase, EC 
2.7.1.36) catalyzes the phosphorylation of mevalonate at the five 
position as shown in Figure 1. The first reported isolation and 
purification of mevalonate kinase was in 1958 by Tchen (48) from a 
yeast autolysate. Mevalonate kinase from a large number of sources 
have been studied. These include pumpkin seedlings (49), rubber plant 
latex (50), bean seedlings (51, 52, 53, 54), orange fruit (55), pine 
seedlings (56), N. cataria (57), hog liver (58, 59), chicken and rat 
liver (60, 61). The phosphorylation of mevalonate by hog liver 
mevalonate kinase has been shown to be an ordered sequential reaction 
in which mevalonate adds first followed by MgATP, then 5-phosphomeval-
onate is released first followed by ADP (58). ATP is the nucleotide 
that best supports phosphorylation of mevalonate; however, in different 
systems other nucleotides can also serve as phosphate donors (48, 49). 
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inhibition of enzymatic activity by high levels of ATP has been 
reported (48, 55). Divalent cations are required for activity with 
Mg++ and Mn++ giving the best activity although other divalent cations 
will also support low levels of phosphorylation (48, 49, 50). An 
active -SH group is suggested in mevalonate kinase by its sensitivity 
to sulfhydryl binding agents (48, 49, 50, 53, 54, 55) and the require-
ment for sulfhydryls in isolation buffers (57). The pH optimum of 
mevalonate kinase varies with source, with a minimum pH optimum of 
5.5 to a maximum of 9.0 (49, 50). 
It has been suggested that there are two pools of mevalonate 
kinase in plants. The chloroplastidic pool with a pH optimum of 7.5 
and the extra-chloroplastic pool with a pH optimum of 5.5 (51). 
Mevalonate kinase can be inhibited by a number of products 
including geranyl pyrophosphate (54, 58, 61, 62), farnesyl pyrophos-
phate (54, 60, 61, 62) and higher prenylpyrophosphates (54, 62). ADP 
and 5-phosphomevalonate have also been shown to inhibit the enzyme 
(54, 58). The molecular weight of mevalonate kinase from a number of 
sources has been estimated to be 100,000 daltons (60). 
3. 5-Phosphomevalonate Kinase 
5-Phosphomevalonate kinase (ATP:5-phosphomevalonate phosphotrans-
ferase, EC 2.7.4.2) catalyzes the second phosphorylation by ATP at the 
5 position of 5-phosphomevalonate. The enzyme has been partially 
purified from a number of sources including rubber latex (63), pine 
(64), yeast (65), and hog liver (59). ATP is the only nucleotide to 
support phosphorylation (63, 65). A divalent cation is required with 
++ ++ i+ ++ +!-Mg , Fe and Zn activating best, and Mn and Ca supporting low 
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levels of phosphorylation (63, 65). The pH optimum varies with source 
and ranges from pH 5.5 to 7.4. Sulfhydryl reagents tend to increase 
the activity of 5-phosphomevalonate kinase from pine (64) and rubber 
latex (63). 
4. 5-Pyrophosphomevalonate Decarboxylase 
5-Pyrophosphomevalonate decarboxylase (ATP:5-pyrophosphomevalonate 
carboxy-lyase, EC 4.1.1. 33) is the. enzyme catalyzing the synthesis of 
active isoprene units. This enzyme is the most difficult of all the 
mevalonate activating enzymes to be isolated from hog liver (59). 
Better yields have been reported from yeast autolysates (65, 66) and 
the decarboxylase, free of kinase and phosphatase activities, has been 
purified from rubber latex (63). 5-Pyrophosphomevalonate decarboxylase 
from yeast has a pH optimum from 5 to 10 (65). In rubber latex a 
broad peak of activity with an optimum at pH 6.4 is observed (63). 
++ ++ ++ Mg , Mn and Co are the cations that best activate the decarboxy-
lase (63). Sulfhydryl binding reagents have been shown to have no 
effect on decarboxylase activity from some systems (63); iodoacetamide 
has been shown to decrease isopentenyl pyrophosphate levels in other 
preparations of the decarboxylase from rubber latex (50). ATP con-
centrations of 10- 4 molar are optimum for activity and concentrations 
higher than 10- 2 molar are inhibitory (63, 65). ADP and isopentenyl 
pyrophosphate inhibit decarboxylase activity in the rubber latex 
system (63). 
CHAPTER III 
MATERIALS AND METHODS 
A. Materials 
1. Plants 
_!!. cataria plants were grown in a vermiculite-soil mixture in the 
Oklahoma State University horticulture greenhouse or in a Percival 
controlled environmental growth chamber under 16 hour light periods 
with mixed Grow-Lux-incandescent illumination. Light period tempera-
ture was held at 32°C and dark period temperatures were lowered to 
21°C. Plants were either propagated vegetatively or grown from seeds. 
2. Plant Cell Culture 
B_. cataria cell cultures were initiated and maintained according 
to the procedure described by Downing and Mitchell (57). 
3. Radioactive Compounds 
Mevalonate-2- 14C, B-hydroxymethyl-B-methylglutaryl CoA-(HMG-CoA)-
3-14C and Instagel were purchased from New England Nuclear, Boston, 
Massachusetts. The labelled mevalonate was obtained as the dibenzoyl-
ethylenediamine salt with a specific activity of 6.3-7.1 microcuries 
per micromole of acid. The HMG-CoA was obtained in an aqueous solution 
pH 8.0 with a specific activity of 26.2-26.4 microcuries per micromole. 
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4. Chemicals and Reagents 
Solvents and reagents were of analytical grade or of the highest 
quality available unless otherwise specified. 
Bio-Gels were purchased from Bio-Rad Laboratories, Richmond, 
California. Dowex ion exchange resins were purchased from Sigma 
Chemical Company, St. Louis, Missouri. Diaflow ultrafilter apparatus 
and membranes were purchased from Amicon Corporation, Lexington, 
Massachusetts. 
Whatman number one chromatography paper was purchased from 
Sargent-Welch in large lots, such that all sheets would be of the 
same production number, so as to obtain papers with the most nearly 
uniform flow rate possible. 
Polyclar AT (polyvinyl pyrolidone washed in acid) was the generous 
gift of the GAF Corporation, New York, New York. 
Thin layer supplies were purchased from Brinkman Instruments, 
Westbury, New York. 
5. Enzymes, Substrates and Cofactors 
Rabbit muscle pyruvate kinase, beef heart lactate dehydrogenase 
and yeast glucose-6-phosphate dehydrogenase were purchased from Sigma 
Chemical Company, St. Louis, Missouri. 
ATP and ADP in the sodium salt form, phosphoenolpyruvate as 
+ the trisodium or tricyclohexylamine salt, NAD, NADH and NADP as the 
sodium salts, glucose-6-phosphate as the disodium salt, S-glycerol 
phosphate, R,S-mevalonate as the lactone and (R,S) HMG-CoA were 
purchased from Sigma Chemical Company, St. Louis, Missouri. 
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B. Methods 
1. Preparation of Cell-Free Extracts 
Cell-free extracts of leaf and callus tissue were prepared by 
grinding the material with sand, Polyclar AT and homogenization buffer, 
500 mM MgCl2, 1 mM EDTA, 0.5 mM dithiothrietol, 0.1 mM potassium 
mevalonate, 500 mM Tris pH 7.5, in a mortar until a smooth homogenous 
paste was obtained. A 1:1 (w/v) ratio of tissue to homogenization 
buffer and a 1:10 (w/v) ratio of Polyclar AT to tissue was used in 
all cell-free preparations. 
The smooth paste obtained on grinding of the tissue was pressed 
through six layers of cheese cloth and the exudate was subjected to 
a series of centrifugations as described in Figure 2. All procedures 
were carried out at 4°C using precooled mortar and buffers. 
2. Preparation of Microsomes 
A homogenate paste was obtained from leaf tissue in a similar 
manner as described in the preparation of cell free extracts. The 
homogenate was then subjected to a series of centrifugations as 
described in Figure 3. The 3,000 x g pellet contained whole chloro-
plasts and cells. The 30,000 x g pellet contained mitochondria. The 
150,000 x g 2 hour pellet contained broken chloroplasts and ribosomes. 
The 150,000 x g 16 hour pellet contained the microsomal membranes. 
3. Chloroplast Isolation 
Chloroplasts were isolated by the method of R. G. Jensen and J. 
A. Bassham (67) with one modification, in that the leaf tissue was 
Figure 2. Preparation of Cell Free Extract 
3,000 x G PELLET 
30,000 x G PELLET 
HOMOGENATE 
l 
6 LAYERS 
CHEESECLOTH 
l 
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3,000 x G, 20 MIN 
3,000 x G SUPERNATANT 
l 
30,000 x G, 20 MIN 
30,000 x G SUPERNATANT 
(CELL-FREE EXTRACT) 
Figure 3. Purification of Mevalonate Kinase by Differential 
Centrifugation 
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homogenized with five second burst five times. The mildly homogenized 
leaf tissue was pressed through six layers of cheese cloth and the 
exudate was centrifuged at 2,000 x g for 50 seconds. The pellet con-
tained the whole chloroplasts. For experiments the whole chloroplasts 
were homogenized before centrifugation on a sucrose density gradient. 
4. Sucrose Gradient 
A discontinuous sucrose gradient of 20%-45% was used in all 
experiments. The sucrose solutions were made up in buffer containing 
100 mM Tris pH 7.5, 10 mM MgC1 2 , 1 mM EDTA, 0.5 mM dithiothreitol, 
and 0.1 mM potassium mevalonate. The concentration of sucrose was 
checked with a refractometer. 
The gradient consisted of 5.3 ml of each of the following sucrose 
concentrations: 20%, 25%, 30%, 34% and 38% layered on 3.2 ml of 45% 
sucrose solution. Fractions of either three or six ml were removed 
by using a density gradient fractionator and dialyzed against buff er 
containing 100 mM Tris ph 7.5, 10 mM MgC1 2 , 0.5 mM DTT and 0.1 mM 
potassium mevalonate. 
5. Assays 
Protein concentrations were determined by a modification of the 
Lowry procedure as described by Hartree (68) using bovine serum 
albumin as a standard. 
Alkaline phosphatase assays were performed as described for the 
E. coli enzyme (69). 
Mevalonate kinase activity was measured by a radioactive assay 
based on a method described by Green and Levinthal (70). The assay 
system included MgC1 2 , ATP, dithiothreitol, a-glycerol phosphate and 
enzyme sources as indicated for individual experiments. Assays were 
run at 30°C for the time periods specified. 
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The reactions were performed in a total volume of 0.5 to 1.0 ml 
and were terminated by innnersion in boiling water for three to five 
minutes. The precipitated protein was removed by centrifugation and 
the supernatant was applied to a Dowex-1 formate column for separation 
of products. 
HMG-CoA reductase activity was measured by two similar radioactive 
assays. One assay was based on a method by Haber et al., (71) with 
some modifications. The reaction mixture in a volume of 1.0 ml con-
tained 1 mM of EDTA, 1 mM of dithiothreitol, 10 mM of glucose-6-phos-
phate, 1 mM of disodium NADP+, 2 units of glucose-6-phosphate 
dehydrogenase, and various amounts of 3-14C-HMG-CoA and protein as 
indicated for individual experiments. Incubations were carried out 
at 37°C for the time specified in each experiment. The reaction was 
stopped by quick freezing in acetone and dry ice. Mevalonic acid 
lactone was formed by the addition of 200 µl of 2 !'i_ H2S04. The reac-
tion mixture was allowed to set at room temperature for 10 minutes in 
order for lactonization to occur. This mixture was lypholyzed, 
extracted with ether 4 times (1 x 9.5 ml and 3 x 4.5 ml) and the ether 
extracts were evaporated to dryness. The residue was dissolved in 
0.5 ml of water and placed on a Dowex-1 formate column which was 
eluted with 5.0 ml of water. The eluate, which contained the mevalon-
alactone was collected in a scintillation vial and 10 ml of Instagel 
was added. The scintillation vial was then counted in a 3320 Packard 
scintillation spectrometer. 
A second assay was used to detect other products formed. The 
reaction mixture was the same as described for the previous HMG-CoA 
reductase assay. After termination of the reaction by immersion in 
boiling water for three to five minutes, the precipitated protein 
was removed by centrifugation and the supernatant was applied to a 
Dowex-1 formate column. The elution was started by using three 
chambers containing SO ml H2 0, SO ml 1 N formic acid and SO ml 2 N 
formic acid, followed by a discontinuous gradient consisting of 50 
ml elutions of 4 N formic acid, 50 ml of 4 N formic acid and 0.4 N 
arrnnonium formate, and finally 50 ml of 4 N formic acid and 0.8 N 
ammonium formate. Using an ISCO "pup" fraction collector at 60 drops 
per fraction was obtained, collected in approximately 3 ml fractions 
and 100 µl of each fraction was removed for scintillation counting. 
6. Chromatography 
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Descending paper chromatography for the identification of meval-
onate, HMG and HMG-CoA was done on Whatman lil paper. The solvent used 
was n-propanol:arrnninium hydroxide (7:3 v/v). Chromatography chambers 
were equilibrated with the solvent for at least 24 hours prior to use. 
The chromatograms were placed in the chamber and the system was allowed 
to equilibrate for an additional hour before introducing the elution 
solvent. 
Ion exchange chromatography of mevalonate metabolites on Dowex-1 
(formate form) columns was completed as described by Suzue (72) over 
0.5 x S.O cm columns collecting 3.3 ml fractions. Stepwise elution of 
Dowex-1 formate columns was achieved with: a) 25 ml H20; b) 2S ml 
2 N formic acid; c) 50 ml 4 N formic acid; d) 50 ml 0.4 !! ammonium 
formate in 4 N formic acid and e) 50 ml 0.8 ammonium formate in 4 N 
formic acid. 
The resin for the Bio-Gel P-100 column was treated and poured as 
described in the Gel Chromatography manual by Bio-Rad Laboratories. 
The colunm was equilibrated with 100 mM Tris pH 7.5 prior to use. 
7. Detection and Measurement of Radioactivity 
Radioactivity on chromatograms was detected either by autoradio-
graphy or by cutting chromatograms into ~ inch strips and counting 
each strip in a toluene-ethanol scintillation counting cocktail. 
Radioactive elution profiles from ion exchange chromatography columns 
were obtained by counting an aliquot of each fraction in a toluene-
ethanol or Instagel scintillation counting cocktail. The toluene-
ethanol scintillation cocktail was composed of four grams of 2,5 
diphenyloxazole (PPO) and 0.2 grams of 1,4-bis (2-(5-phenyloxazole))-
benzene; phenyloxazolylphenyl (POPOP) in 400 ml sulfur free toluene 
and 600 ml absolute ethanol. All samples were counted in ten ml 
volumes. 
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A standard quench set was prepared utilizing 14 C benzoic-acid as 
the isotopic source with various amounts of reagent grade acetone used 
as a quencher. Samples counted in toluene-ethanol and Instagel cocktail 
were determined to be between 50 and 75 percent efficient. 
8. Partial Purification of HMG-CoA Reductase 
and Mevalonate Kinase from N. Cataria Leaf and 
Callus Tissue 
The cell-free extract was brought to 30% saturation (160 g/l) with 
a-minium sulfate and centrifuged at 3,000 x g for 20 minutes. The 
30% anunonium sulfate supernatant was brought to 70% saturation by the 
addition of 260 g/l of ammonium sulfate and centrifuged at 3,000 x g 
for 20 minutes. The 70% pellet was resuspended in a minimum volume 
of buffer (100 mM Tris pH 7.5, 10 mM MgC1 2 , 1.0 mM EDTA, 0.5 mM 
dithiothreitol, 0.1 mM potassium mevalonate) and dialyzed against the 
same buffer without EDTA. One ml of the dialyzed pellet solution 
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(22 to 31 mg of protein) was placed on a 30 ml 20-45% discontinuous 
sucrose gradient. Six fractions of five mls each were collected. The 
fraction containing either the kinase or reductase activities were 
again dialyzed against the buffer previously described. The dialyzed 
fraction was concentrated by using a Diaflow ultrafilter apparatus. 
The concentrated fraction was applied to a Bio-Gel P-100 column eluted 
with the same buffer used in resuspending the 70% pellet and two ml 
fractions were collected. Figure 4 gives a detailed flow chart of the 
procedure. 
9. Partial Purification of HMG-CoA Reductase 
and Mevalonate Kinase from Manunalian and Avian 
Tissue 
The manunalian and avian tissues utilized were hog liver, turkey 
kidney and turkey liver. The cell-free extract was obtained by homo-
genizing the tissue in a blender using 15 second bursts until a smooth 
homogenate was obtained. The buffer used was the same as described for 
N. cataria tissue except 50 mM sucrose was used. The remaining steps 
of purification were carried out as described in Figure 4. The 
Figure 4. Purification of Mevalonate Kinase and HMG-CoA Reductase 
by Ammonium Sulfate Fractionation 
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purification of mammalian and avian HMG-CoA reductase and mevalonate 
kinase was not carried out past the sucrose gradient step. 
10. Partial Purification of Mevalonate Kinase 
from Yeast 
Mevalonate kinase was solubilized from Fleischmann's active dry 
yeast for bakers by a modification of the autolysis procedure of 
Kirtley and Rudney (73). The liquid nitrogen freezing step prior to 
autolysis was omitted. One hundred grams of dry yeast was suspended 
in 200 ml of 100 mM Tris pH 7.5, 0.5 rnM dithiotheritol, 1 mM EDTA, 
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10 rnM MgC1 2 and 0.1 rnM potassium mevalonate. The suspended yeast was 
stirred 12 hours at 4°C. The suspension was centrifuged at 20,000 x g 
for 20 minutes. The supernatant was assayed and discarded. The gummy 
precipitate was resuspended in 200 ml of the same buffer and stirred 
for another 48 hours at 4°C. The suspension was centrifuged as before. 
This step resulted in considerable portion of the enzyme being 
solubilized. The supernatant was next certtrifuged at 30,000 x g for 
20 minutes. The supernatant from the 30,000 x g centrifugation was 
then subjected to the steps described in Figure 4. The purification 
was terminated after the sucrose gradient step. 
CHAPTER IV 
RESULTS AND DISCUSSION 
A. Mevalonate Activating Enzymes 
1. Plants 
a. Purification. The purification of mevalonate kinase from N. 
cataria leaf tissue outlined in Figure 3 is an extension of the method 
described by Downing and Mitchell (57). Mevalonate kinase, 5-phos-
phomevalonate kinase and 5-pyrophosphomevalonate decarboxylase activi-
ties were observed in the 30 to 70 percent ammonium sulfate precipitate. 
Figure 5 gives a profile of products from mevalonate metabolism on a 
Dowex-1 formate column. A yield of 21 percent of the total units and 
a 2.1 fold purification was observed at the 30 to 70 percent ammonium 
sulfate precipitate as seen in Table I. 
The 30-70 percent ammonium sulfate pellet was dialyzed and 1 ml 
(22 to 31 mg/ml) was layered on a 20-45% discontinuous sucrose 
gradient as described in methods. The gradient was centrifuged at 
20,000 x g for three hours and five fractions of six mls each were 
collected. Figure 6 shows the elution profile of protein concentration 
and mevalonate kinase activity from the 20 to 45 percent discontinuous 
sucrose gradient. Mevalonate kinase is measured as total phosphoryla-
ted products rather than 5-phosphomevalonate. The assay mixture 
contained 10.0 mM MgC1 2 , 5 mM ATP, 0.5 mM dithiothreitol, 1.0 mM EDTA, 
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Figure 5. Dowex-1 Formate Elution Pattern: Mevalonate Kinase Assay 
of 30 to 70 Percent Ammonium Sulfate Pellet from Leaf 
Tissue 
Elution profile following assay of leaf 30 to 70 percent 
ammonium sulfate pellet under standard assay condition 
for mevalonate kinase. Elution of Dowex-1 formate 
columns: 
A. 25 ml of water 
B. 25 ml of 2 N formic acid 
c. 50 ml of 4 N formic acid 
D. 50 ml of 4 N formic acid + 0.4 N ammonium formate 
E. 50 ml of 4 N formic acid + 0.8 N ammonium formate 
Collect approximately 3.0 ml fractions 
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TABLE I 
PURIFICATION OF MEVALONATE KINASE FROM N. CATARIA LEAF 
Step Volume Concentration Total Protein Specific (a) Yield Purification 
ml Units/ml Units Mg/ml Activity 
Crude Homogenate 60.0 410 24,500 17.8 .024 100.0% 1.00 
3,000 x g Supernatant 55.0 422 23,210 15.0 .028 94.0% 1.19 
30,000 x g Supernatant 52.0 486 25 ,272 14.0 .035 102.0% 1.47 
Ammonium Sulfate Fractionation 
30% Supernatant 47.0 392 18,424 9.2 .043 75.0% 1.81 
30% Pellet 5.3 0 0 2.3 .o o.o o.o 
70% Supernatant 44.0 15 660 6.2 .002 3.0% 0.10 
70% Pellet 10.2 990 10,098 9.7 .051 41.2% 2.14 
Sucrose Gradient 
Fraction Ill 18.0 258 4,644 1.33 .194 18.9% 8.2 
Fraction fl 3 18.0 105 1,890 1.02 .103 7.8% 4.4 
P-100 Column - - - - -
Fraction #10 9.0 427 3,843 0.42 1.068 15.6% 45.3 
w 
(a)specific Activity . -1 -1 
w 
Units are given in nanomoles of mevalonate metabolized min mg 
Figure 6. Protein and Mevalonate Kinase Activity Profile from 20 to 
45 Percent Sucrose Gradient 
Centrifugation of a 30 to 70 percent annnonium sulfate pre-
cipitate from leaf tissue. Protein (---), Mevalonate 
kinase (-) 
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110 mM DL-[2- 14C) mevalonate (sp. act. 4.6-5.9 x 10 3 DPM/µmole) and 
10 µM a-glycerol phosphate in a total volume of one ml. Figure 7 
shows the effect of 10 µM a-glycerol phosphate on the mevalonate 
kinase activity isolated from the first fraction of the sucrose 
gradient. 
Table II shows the effect that 10 µM a-glycerol phosphate has 
on the two mevalonate metabolizing systems found in the sucrose 
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gradient. Fraction one shows a four-fold increase in product formation 
whereas fraction three product formation remains virtually unchanged. 
These data suggest that fraction one contains contaminating non-
specific phosphatase enzymes since the addition of a-glycerol phosphate, 
a phosphatase inhibitor, increases the amount of phosphorylated 
products formed. Likewise fraction three is relatively free of non-
specific phosphatase activities. 
TABLE II 
EFFECT OF a-GLYCEROL PHOSPHATE 
Fraction 1 
Fraction 3 
-S-Glycerol Phosphate 
nmoles/min mg 
.018 
.086 
+S-Glycerol Phosphate 
nmoles/min mg 
.081 
.089 
Figure 7. Effect of B-Glycerol Phosphate on Mevalonate Kinase Activity 
From Fraction One of 20 to 45 Percent Sucrose Gradient 
Centrifugation of 30 to 70 Percent Annnonium Sulfate Preci-
pitate of Leaf Tissue 
Dowex-1 formate elution profiles following assay of 
fraction one of discontinuous 20 to 45 percent sucrose 
gradient (A) under standard assay conditions, (B) under 
standard assay conditions plus 10 µM B-glycerol phosphate. 
Elution of Dowex-1 formate columns: 
A. 25 ml of water 
B. 25 ml of 2 N formic acid 
c. 50 ml of 4 N formic acid 
D. 50 ml of 4 N formic acid + 0.4 N ammonium formate 
E. 50 ml of 4 N formic acid + 0.8 N ammonium formate 
Collect approximately 3.0 ml fractions 
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Fractions one and three also contain 5-phosphomevalonate kinase 
as well as mevalonate kinase activity. Fraction one contains 5-pyro-
phosphomevalonate decarboxylase activity, but fraction three contains 
very little of this activity (Figure 8). 
Fraction one from the sucrose gradient was dialyzed against the 
same buffer as previously described, concentrated to 1.5 ml on a 
Diaflow-membrane apparatus and run on a Bio-Gel P-100 column (2 x 40 
cm) which was equilibrated with 100 mM ·Tris pH 7.5, 10 mM MgCl2, 1 mM 
-· -
mevalonate. The elution profile is shown in Figure 9. Only one peak 
of mevalonate kinase activity was observed. The kinase activity 
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eluted in the void volume of the P-100 column. The partially purified 
mevalonate kinase as reported in Table I, had a specific activity of 
1.068 nmoles of mevalonate metabolized per minute per mg of protein. 
This represented a purification of nearly 50 fold. 
The mevalonate kinase obtained from the P-100 column void volume 
was found to be stable at 4°C for up to three weeks. The enzyme was 
also stable to lyophilization and could be stored in this form. 
Co-purification of mevalonate kinase, 5-phosphomevalonate kinase 
and 5-pyrophosphomevalonate decarboxylase through the Bio-Gel P-100 
column chromatography step is demonstrated by the elution profile of 
the products on Dowex-1 formate column (Figure 10). This observation 
indicates that the enzymes are either all physically similar and of 
high molecular weight or associated in an enzyme-like complex. The 
suggestion of a high molecular weight multi-enzyme complex is con-
sistent with the ideas expressed by Banthorpe et al., (4) and Francis 
(5) "that the enzymes involved in monoterpene biosynthesis may be 
associated in a multi-enzyme complex with a high degree of spatial 
Figure 8. Effect of a-Glycerol Phosphate on Mevalonate Kinase Activity 
from Fraction Three of 20 to 45 Percent Sucrose Gradient 
Centrifugation of 30 to 70 Percent Ammonium Sulfate Preci-
pitate of Leaf Tissue 
Dowex-1 formate elution profiles following assay of 
fraction one of discontinuous 20 to 45 percent sucrose 
gradient (A) under standard assay conditions, (B) under 
standard assay conditions plus 10 µM a-glycerol phosphate. 
Elution of Dowex-1 formate column: 
A. 25 ml of water 
B. 25 ml of 2 N formic acid 
c. 50 ml of 4 !! formic acid 
D. 50 ml of 4 N formic acid + 0.4 N ammonium formate 
E. 50 ml of 4 N formic acid + 0.8 N armnonium formate 
Collect approximately 3.0 ml fractions 
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Figure 9. Protein and Mevalonate Kinase Activity Profile from Bio-Gel 
P-100 Column of Leaf Tissue 
Protein (~-), Mevalonate kinase (---) 
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Figure 10. Dowex-1 Formate Elution Pattern: Mevalonate Kinase Assay 
of Fraction 10 from Bio-Gel P-100 Column of Leaf Tissue 
Elution profile following mevalonate kinase assay of 
fraction 10 from Bio-Gel P-100 column under standard 
assay conditions. Elution of Dowex-1 column: 
A. 25 ml of water 
B. 25 ml of 2 N formic acid 
c. 50 ml of 4 N formic acid 
D. 50 ml of 4 N formic acid + 0.4 N ammonium formate 
E. 50 ml of 4 N formic acid + 0.8 N ammonium formate 
Collect approximately 3.0 ml fractions 
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organization for efficient substrate circulation." Mevalonate kinase 
from a number of sources has been reported to have a molecular weight 
of approximately 100,000 daltons (29). This corresponds very well with 
the observation that mevalonate kinase activity voids a Bio-Gel P-100 
column, which indicates a minimum molecular weight of 100,000 daltons. 
b. Intracellular Location. The observation of two different 
mevalonate metabolizing systems in the plant leaf tissue leads one to 
the question of the intracellular location of these two systems. The 
following experiments were attempted in an effort to localize these 
activities. 
The procedure as described in Figure 2 was used to obtain micro-
somal membranes. The 30,000 x g supernatant was obtained in the same 
manner as described in the previous section. The 30,000 x g supernatant 
contained 93% of the total units as indicated in Table III. The 30,000 
x g supernatant was centrifuged at 150,000 x g for two hours. The 
150,000 x g 2 hour pellet was resuspended in 100 mM Tris pH 7.5, 10 mM 
MgCl2, 1.0 mM EDTA, 0.5 mM dithiothreitol and 0.1 mM mevalonate and 
dialyzed against the same buffer without EDTA. The 2 hour pellet 
contained very little mevalonate kinase activity as shown in Figure 11. 
There was also no alkaline phosphatase activity in the 150,000 x g 
pellet (2 hour). 
The 150,000 x g supernatant was then centrifuged at 150,000 x g 
for 16 hours. The pellet was resuspended and dialyzed as previously 
described. The 150,000 x g 16 hour pellet also contained alkaline 
phosphatase activity. For this reason all assays were carried out in 
the presence of 10 µM a-glycerol phosphate. Figure 12 indicates that 
TABLE III 
MEMBRANE ISOLATION 
Step Volume Concentration Total Protein Specific (a) Yield Specific(b) 
ml Units/ml Units Mg/ml Activity Activity 
Crude Homogenate 60 391 23,460 16.6 .0235 100.0% 
30,000 x g Supernatant 54 405 21,870 13.0 .0312 93.0% 
150,000 x g 2 Hr Pel 3 44 132 9.0 .049 0.6% 
150,000 x g 16 Hr Pel 4 2580 10,320 7.4 .1395 44.4% 1.85 
150,000 x g 16 Hr Sup 46 1 46 8.0 .002 0.2% 0.46 
Sucrose Gradient 
Fraction 1 24 360 8,640 0.91 .1758 36.8 1. 61 
2 24 6 144 0.32 4.7 
3 24 3 72 0.36 2.2 
4 24 2 48 0.24 4.0 
5 24 0 0 0.29 o.o 0 
(a) Specific Activity Units are given in nanomoles of mevalonate formation min- 1 mg -1 
(b) Specific Activity Units are given in nanomoles of p-N0 2 phenyl phosphate hydrolyzed min- 1 -1 mg 
+:'-
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Figure 11. Dowex-1 Formate Elution Pattern: Mevalonate Kinase Assay 
of Pellet from 2 Hour 150,000 x g Centrifugation of Leaf 
Tissue 
Elution profile following mevalonate kinase assay of 
pellet from 150,000 x g centrifugation for 2 hours under 
standard assay conditions. Elution of Dowex-1 column: 
A. 25 ml of water 
B. 25 ml of 2 N formic acid 
c. 50 ml of 4 N formic acid 
D. 50 ml of 4 N formic acid + 0.4 N ammonium formate 
E. 50 ml of 4 N formic acid + 0.8 N annnonium formate 
Collect approximately 3.0 ml fractions 
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Figure 12. Dowex-1 Formate Elution Pattern: Mevalonate Kinase Assay 
of Pellet from 16 Hour 150,000 x g Centrifugation of 
Leaf Tissue 
Elution profile following mevalonate kinase assay of 
pellet from 150,000 x g centrifugation for 16 hours 
under standard assay conditions. Elution of Dowex-1 
column: 
A. 25 ml of water 
B. 25 ml of 2 N formic acid 
c. 50 ml of 4 N formic acid 
D. 50 ml of 4 N formic acid + 0.4 N anunonium formate 
E. 50 ml of 4 N formic acid + 0.8 N annnonium formate 
Collect approximately 3.0 ml fractions 
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5-phosphomevalonate kinase as well as mevalonate kinase activity is 
present in the 16 hour pellet. The ratio of 5-phosphomevalonate to 
5-pyrophosphatemevalonate is 32:18. This is the first report of 
mevalonate kinase being associated with a particulate fraction in 
plant tissue. The fact that a pellet was obtained after 16 hours at 
150,000 x g also suggests that the protein (enzymes) are very large 
and are perhaps aggregated. 
52 
One ml of the dialyzed 16 hour pellet were layered on a 30 ml 
20-45% sucrose gradient. The gradient was centrifuged at 20,000 x g 
for three hours and five fractions of six mls was collected. The 
fractions were dialyzed in similar manner as for the 2 hour pellet and 
then assayed for mevalonate kinase and alkaline phosphatase. Figure 
13 and Table III indicate that the bulk of mevalonate kinase activity 
and alkaline phosphatase are both in fraction one. The profile of 
products on the Dowex-1 formate column (Figure 14) shows that 5-phos-
phomevalonate kinase is also present in fraction one. The ratio of 
5-phosphomevalonate to 5-pyrophosphomevalonate is 31:19. This ratio 
of products is virtually the same as obtained from the resuspended 16 
hour pellet which was 32:18. The presence of mevalonate kinase and 
5-phosphomevalonate kinase in the same fraction throughout purification 
and the observation that the ratio of products remains constant 
suggest the possibility that either mevalonate kinase and 5-phospho-
mevalonate kinase may be associated in some form or the reaction is 
catalyzed by the same enzyme or protein. This suggestion needs further 
study. 
Figure 13. Protein and Mevalonate Kinase Activity Profile from 20 to 
45 Percent Sucrose Gradient Centrifugation of 16 Hour 
Pellet from Leaf Tissue 
Protein(---), Mevalonate Kinase (~) 
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Figure 14. Dowex-1 Formate Elution Pattern: Mevalonate Kinase Assay 
of Fraction One from 20 to 45 Percent Sucrose Gradient 
Centrifugation of 16 Hour Pellet from Leaf Tissue 
Elution profile following mevalonate kinase assay of 
fraction one from 20 to 45 percent discontinuous sucrose 
gradient of 16 hour pellet under standard assay condi-
tions. Elution of Dowex-1 column: 
A. 25 ml of water 
B. 25 ml of 2 N formic acid 
c. 50 ml of 4 N formic acid 
D. 50 ml of 4 N formic acid + 0.4 N annnonium formate 
E. 50 ml of 4 N formic acid + 0.8 N ammonium formate 
Collect approximately 3.0 ml fractions 
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2. Chloroplast Isolation 
Whole chloroplasts were isolated by a modified method of Bassham 
and Jensen (67). Leaf tissue was homogenized in 50 mM MES pH 6.1, .20 
mM NaCl, 330 mM sorbitol, 2 mM NaN0 3 , 2 mM EDTA, 2 mM Na isoascorbate, 
1 mM MnCl2, 1 mM MgC12 and 0.5 mM K2HP04. The leaf homogenate was 
centrifuged at 2,000 x g for 50 seconds. The 2,000 x g pellet was 
resuspended in 1 ml of 50 mM HEPES pH 6.7, 20 mM NaCl, 330 mM sorbitol, 
2 mM NaN0 3 , 2 mM EDTA, 2 mM Na isoascorbate, 1 rnM MnCl2, 1 mM MgCl2 
and 0.5 mM K2HP0 4 and centrifuged again at 2,000 x g for 50 seconds. 
Examination by light microscopy showed whole chloroplasts. The pellet 
was resuspended as before and homogenized. The homogenized chloro-
plasts were placed on a 30 ml 20-45% sucrose gradient and centrifuged 
at 20,000 x g for three hours. Five fractions of six mls each were 
collected and assayed for mevalonate kinase activity. 
Mevalonate kinase activity was found to be present only in 
fraction three. Figure 15 shows the product profile from a Dowex-1 
formate column of the third fraction. Fraction three was shown 
to contain both mevalonate kinase and 5-phosphomevalonate kinase 
activities. These findings show that the mevalonate kinase activities 
are located in the microsomal membranes and chloroplasts in the leaf 
tissue of N. cataria. Rodgers, Shah and Goodwin (46) have also 
reported mevalonate kinase activity in the chloroplast fraction. 
3. Callus Tissue from N. Cataria 
Callus tissue from N. cataria was homogenized in a similar fashion 
as described for leaf tissue. The homogenate was centrifuged at 3,000 
Figure 15. Dowex-1 Formate Elution Pattern: Mevalonate Kinase Assay 
of Fraction Three from 20 to 45 Percent Sucrose Gradient 
Centrifugation of Homogenized Chloroplasts from Leaf 
Tissue 
Elution profile following mevalonate kinase assay of 
fraction 3 from 20 to 45 percent discontinuous sucrose 
gradient of homogenized chloroplasts under standard assay 
conditions. Elution of Dowex-1 column: 
A. 25 ml of water 
B. 25 ml of 2 N formic acid 
c. 50 ml of 4 N formic acid 
D. 50 ml of 4 N formic acid + 0.4 N anunonium formate 
E. 50 ml of 4 N formic acid + O. 8 N ammonium formate 
Collect approximately 3.0 ml fractions 
I 
...J 
~ 
::E 
a. 
0 
MVA. 
10 
~ 5 IK 0.1 K 
1-
<t 
...J 
w 
ex: 
MVAP 
MVAPP 
FRACTION 
59 
60 
60 
x g for 20 minutes. The pellet was discarded and the supernatant was 
centrifuged at 30,000 x g for 20 minutes. The 30,000 x g supernatant 
was dialyzed and 1.5 ml of the 30,000 x g supernatant was applied to a 
30 ml 20-45% sucrose gradient. Five fractions of six mls each were 
collected, dialyzed and assayed for mevalonate kinase activity. Figure 
16 is a profile of protein and mevalonate kinase activity in each of 
the fractions. Only one mevalonate kinase activity profile was 
observed, that being in fraction one which is the activity correspond-
ing to the microsomal activity described in the leaf tissue. The 
product profile of fraction one, Figure 17, indicates that 5-phospho-
mevalonate kinase and 5-pyrophosphomevalonate decarboxylase are also 
present. 
Callus tissue is markedly lacking in chloroplast. If one of the 
two mevalonate kinase activities is in the chloroplast, one could not 
expect to find two mevalonate kinase activities in callus tissue. The 
observation of only one mevalonate kinase activity in callus tissue 
lends further support to the idea that terpenoid compounds are synthe-
sized in the chloroplasts. 
4. Comparison of Mevalonate Activating Enzymes 
from N. Cataria Leaf and Callus, Hog Liver and 
Yeast 
Mevalonate kinase activity was found to be in the 30-70% ammonium 
sulfate precipitate in hog liver and yeast tissue. 
The 30-70% pellet from both sources was resuspended and dialyzed 
as described from the plant tissue. Then one ml of the dialyzed 
pellet was placed on 30 ml 20-45% sucrose gradient. Five fractions 
Figure 16. Protein and Mevalonate Kinase Activity Profile from 20 to 
45 Percent Sucrose Gradient Centrifugation of 30 to 70 
Percent Ammonium Sulfate Precipitate from Callus 
Protein(---), Mevalonate Kinase (~-) 
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Figure 17. Dowex-1 Formate Elution Pattern: Mevalonate Kinase Assay 
of Fraction One from 20 to 45 Percent Sucrose Gradient 
Centrifugation of 30 to 70 Percent Ammonium Sulfate Pre-
cipitate from Callus 
Elution profile following mevalonate kinase assay of 
fraction one from 20 to 45 percent discontinuous sucrose 
gradient of callus under standard assay conditions. 
Elution of Dowex-1 column: 
A. 25 ml of water 
B. 25 ml of 2 N formic acid 
c. 50 ml of 4 N formic acid 
D. 50 ml of 4 N formic acid + 0.4 N ammonium formate 
E. 50 ml of 4 N formic acid + 0.8 N annnonium formate 
Collect approximately 30 ml fractions 
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were collected and assayed for mevalonate kinase activity. Figure 18 
shows the profile of protein and mevalonate kinase activity from the 
gradient of the yeast tissue. Just as in the callus, only one meval-
onate kinase activity was observed, that being fraction one. Figure 
19 is the profile from hog liver and again one major peak of activity 
is in fraction one. The product profiles of the fractions with 
activity are shown in Figure 20. The yeast (Figure 20 A) like the 
plant system shows some decarboxylase activity, but the hog liver 
(Figure 20 B) does not. 
5. Mevalonate Kinase from Turkey Liver and 
Kidney 
65 
Cell-free extracts from quick frozen (liquid nitrogen) turkey 
kidney and liver tissue was obtained by homogenizing 100 grams of 
tissue in a blender with a 100 ml homogenization buffer. (The homo-
genization buff er was the same as the buff er described in Preparation 
of Cell-Free Extracts with the exception that 50 mM sucrose was used.) 
Cell-free extracts from turkey kidney were subjected to the 
procedure described in Figure 3. The mevalonate kinase activity was 
found in the 30 to 70% ammonium sulfate precipitate. The 30 to 70% 
ammonium sulfate pellet was resuspended, dialyzed and placed on a 30 
ml 20-45% sucrose gradient as described for the mevalonate kinase 
isolated from N. cataria (6.4 mg/ml). 
The product profile from the Dowex-1 formate column, shown in 
Figure 21, indicates that both mevalonate kinase and 5-phosphomevalo-
nate kinase activity are present (1.2 mg/ml). The ratio of 5-phos-
phomevalonate to 5-pyrophosphomevalonate is 57:43 or 1.33. 
Figure 18. Protein and Mevalonate Kinase Activity Profile from 20 to 
45 Percent Sucrose Gradient Centrifugation of 30 to 70 
Percent Ammonium Sulfate Precipitate from Yeast Auto-
lysates 
Protein (---), Mevalonate Kinase (~) 
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Figure 19. Protein and Mevalonate Kinase Activity Profile from 20 to 
45 Percent Sucrose Gradient Centrifugation of 30 to 70 
Percent Annnonium Sulfate Precipitate from Hog Liver 
Tissue 
Protein(---), Mevalonate Kinase (~) 
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Figure 20. Dowex-1 Formate Elution Pattern: Mevalonate Kinase Assay 
of Fraction One from 20 to 45 Percent Sucrose Gradient 
Centrifugation of (A) Yeast and (B) Hog Liver 
Elution profiles following assay for mevalonate kinase of 
(A) yeast and (B) hog liver fraction one from 20 to 45 
percent discontinuous sucrose gradient under standard 
assay conditions. Elution of Dowex-1 column: 
A. 25 ml of water 
B. 25 ml of 2 N formic acid 
c. 50 ml of 4 N formic acid 
D. 50 ml of 4 N formic acid + 0.4 N annnonium formate 
E. 50 ml of 4 N formic acid + 0.8 N ammonium formate 
Collect approximately 30 ml fractions 
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Figure 21. Dowex-1 Formate Elution Pattern: Mevalonate Kinase Assay 
of the 30 to 70 Percent Ammonium Sulfate Precipitate 
from Turkey Kidney 
Elution profile following assay for mevalonate kinase 
of turkey kidney 30 to 70 percent ammonium sulfate 
precipitate under standard assay conditions. Elution 
of Dowex-1 column: 
A. 25 ml of water 
B. 25 ml of 2 N formic acid 
c. 50 ml of 4 N formic acid 
D. 50 ml of 4 N formic acid + 0.4 N ammonium formate 
E. 50 ml of 4 N formic acid + 0.8 N ammonium formate 
Collect approximately 30 ml fractions 
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The mevalonate kinase activity was found to be in fraction one 
from the sucrose gradient. The product profile shown in Figure 20, 
indicates that very little 5-phosphomevalonate kinase activity remains 
in fraction one. The ratio of 5-phosphomevalonate to 5-pyrophospho-
mevalonate is 83:17 or 4.88 and is very different in the product ratio 
observed in the 30-70% annnonium sulfate pellet. This difference in 
product ratios is strikingly different than that obtained from N. 
cataria in which the two purification steps had identical product 
ratios. This would give an indication that the physical relationships 
of the enzyme systems of mevalonate metabolism is very different in 
N. cataria. 
Turkey liver was removed and quick frozen in liquid nitrogen. 
The frozen tissue was allowed to thaw out and then 100 g of tissue 
was homogenized with 100 ml of homogenation buffer. (Same buffer as 
described for turkey kidney preparation.) This crude homogenate was 
subjected to the purification procedure as described in Figure 3. 
Mevalonate kinase activity was found to be present in the 30-70% 
ammonium sulfate precipitate and this precipitate also contained 5-
phosphomevalonate kinase (9.1 mg/ml). This is shown in Figure 22. 
Again 5-phosphomevalonate is present which indicates the presence 
of mevalonate phosphate kinase. 
B. HMG-CoA Reductase 
L Assay 
S-Hydroxy-S-methylglutaryl-CoA reductase (HMG-CoA reductase) 
catalyses the reduction by NADPH of HMG-CoA to mevalonate. The 
Figure 22. Dowex-1 Formate Elution Pattern: Mevalonate Kinase Assay 
of Fraction One fro~ 20 to 45 Percent Sucrose Gradient 
Centrifugation of the 30 to 70 Percent Ammonium Sulfate 
Precipitate from Turkey Kidney Tissue 
Elution profile following assay for mevalonate 
turkey kidney fraction one of 20 to 45 percent 
ous gradient under standard assay conditions. 
Dowex-1 column: 
A. 25 ml of water 
B. 25 ml of 2 N formic acid 
c. 50 ml of 4 N formic acid 
D. 50 ml of 4 N formic acid + 0.4 N ammonium 
E. 50 ml of 4 N formic acid + 0.8 N ammonium 
Collect approximately 3.0 ml fractions 
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purified enzyme can be assayed spectrophotometrically (74) but in 
crude preparations it must be assayed radiochemically. The connnon 
problem of all radiochemical procedures currently used for assaying 
this enzyme is the separation of the radioactively labelled substrate 
HMG-CoA, HMG or other degradation products from the reaction product 
mevalonate or mevalonolactone. 
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The separation of the substrate and the product has been achieved 
by: 
1. Enzymatic phosphorylation of mevalonate followed by ether 
extraction of HMG (75, 76). 
2. Gas-liquid chromatography (77, 78, 79, 80). 
3. Thin layer chromatography (81, 82, 83, 84). 
4. Thin-layer electrophoresis (85, 86). 
5. Lactionization of mevalonate and isolation (71). 
A method of column chromatography was devised to separate HMG-CoA 
and its breakdown products from the reaction product mevalonate. 
The reaction was performed as described in the methods section. 
A concentration of 15 µM for [3- 14C] HMG-CoA (specific activity 26.5 
mCi/mmole) was used. The reaction mixture was allowed to incubate for 
30 minutes at 37°C and terminated by placing the reaction containers 
in boiling water. The protein was removed by centrifugation and the 
remaining reaction mixture was placed on a Dowex-1 formate column 
(23 x .55 cm). The upper end of the column was tightly connected to 
a small glass funnel. The colllllln was washed with a few ml of water 
and then the reaction mixture was applied. The column was. eluted with 
a 150 ml gradient consisting of three chambers containing 50 ml of H2 0, 
50 ml of N formic acid and 50 ml of 2 N formic acid. The gradient was 
followed by stepwise elutions with 50 ml of 4 N formic acid, 50 ml of 
4 N formic acid and 0.4 N alillllonium formate, and 50 ml of 4 N formic 
acid and 0.8 N anunonium formate. Fractions of 3 ml volumes were 
collected and 100 µl was removed for scintillation counting. 
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Figure 23 gives the elution profile of 3-14C-HMG-CoA when applied 
directly to the column. Figure 24 shows the elution profile of 
3- 14 C-HMG-CoA after incubation at 37°C for 30 minutes (reaction con-
ditions) in 100 mM Tris pH 7.5. The appearance of a second peak is 
observed. This peak coinsides with the peak one obtains when HMG-CoA 
is incubated Mith 100 mM NaOH for three hours at 50°C. (See Figure 
25.) Paper chromatography of this peak confirmed that it was hydroxy-
methylglutarate. Figure 26 shows the elution profile of mevalonate 
(2- 14C). The mixture of 2- 14C-mevalonate and 3- 14C-HMG-CoA which was 
treated with 100 mM NaOH for three hours was applied to the column. 
Two peaks were observed, one corresponding to mevalonate and the other 
to HMG (Figure 27). 
Paper chromatography of each peak was run to confirm that the two 
peaks were mevalonate acid and HMG respectively. Pooled fractions 
containing these two peaks were combined to give two fractions. These 
fractions were evaporated in vacuo dryness and then resuspended in 200 
µl of 10 mM Tris pH 7.5. Twenty µl of each fraction was applied to 
30 inch by 2 inch strips and chromatographed in g-propanol:ammonium 
hydroxide (7:3) as previously described. After the solvent front had 
moved 20 inches from the origin, the chromatogram was removed, allowed 
to air dry, cut into ~ inch strips and then placed in a scintillation 
vial with 10 ml of toluene ethanol cocktail. Standards of 2- 14C-
mevalonate and 3- 14 C-HMG were done in a similar manner. 
Figure 23. Dowex-1 Elution Pattern of HMG-CoA 
Elution of Dowex-1 column: 
AG. Linear gradient of 0-2 B_ formic acid using three 
chambers containing SO ml water, SO ml 1 N formic 
acid and SO ml 2 N formic acid 
c. 50 ml of 4 N formic acid 
D. so ml of 4 N formic acid + 0.4 N ammonium formate 
E. so ml of 4 N formic acid + 0.8 N ammonium formate 
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Figure 24. Dowex-1 Elution Pattern of HMG-CoA After Incubation at 
37°C for 30 Minutes pH 7.5 
Elution of Dowex-1 column: 
AG. Linear gradient of 0-2 ! formic acid using three 
chambers containing 30 ml water, 50 ml 1 N formic 
acid and 50 ml 2 N formic acid 
c. 50 ml of 4 N formic acid 
D. 50 ml of 4 N formic acid + 0.4 N annnonium formate 
E. 50 ml of 4 N formic acid + 0.8 N ammonium formate 
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Figure 25. Dowex-1 Elution Pattern of HMG-CoA After Incubation at 50°C 
for Three Hours in 100 mM NaOH 
Elution of Dowex-1 column: 
AG. Linear gradient of 0-2 B_ formic ac~-d using three 
chambers containing 30 ml water, 50 ml 1 N formic 
acid and 50 ml 2 N formic acid 
C. 50 ml of 4 N formic acid 
D. 50 ml of 4 N formic acid+ 0.4 N ammonium formate 
E. 50 ml of 4 N formic acid+ 0.8 N ammonium formate 
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Figure 26. Dowex-1 Elution Pattern of Mevalonate 
Elution of Dowex-1 column: 
AG. Linear gradient of 0-2 ! formic acid using three 
chambers containing 30 ml water, 50 ml 1 N formic 
acid and 50 ml 2 N formic acid 
c. 50 ml of 4 N formic acid 
D. 50 ml of 4 N formic acid + 0.4 N ammonium formate 
E. so ml of 4 N formic acid + 0.8 N anunonium formate 
86 
10 
-
MVA 
I 
_. 
~ 
::!! 
a.. 
0 
w 5 
> 
..... 
<( 
_. 
w 
a: 
AG 20 E 
FRACTION 
Figure 27. Dowex-1 Elution Pattern of Mevalonate and HMG-CoA After 
Incubation at 50°C for Three Hours in 100 mM NaOH 
Elution of Dowex-1 column: 
AG. Linear gradient of 0-2 B_ formic acid using three 
chambers containing 30 ml water, 50 ml 1 N formic 
acid and 50 ml 2 N formic acid 
c. 50 ml of 4 N formic acid 
D. 50 ml of 4 N formic acid + 0.4 N ammonium formate 
E. 50 ml of 4 N formic acid + 0.8 N anunonium formate 
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Table IV shows the Rf values for the two peaks as well as mevalo-
nate and HMG. 
TABLE IV 
Rf VALUES OF PEAK I & II, MEVALONATE AND 
B-HYDROXYMETHYLGLUTARATE 
2- 14C-mevalonate 
3- 14 C-HMG 
Peak 1 
Fraction 4-5 Dowex-1 formate 
Peak 2 
Fraction 8-11 Dowex-1 formate 
. 69 • 76 
.17 .25 
• 72 • 78 
.20 .26 
89 
Since mevalonate and HMG have similar Rf values on paper as peak 1 
and peak 2 respectively, and also since mevalonate elutes in the same 
fraction as peak 1 on Dowex-1 and HMG elution is identical to peak 2 it 
would appear that mevalonate and HMG can be separated and identified -
peak 1 being mevalonate and peak 2 as HMG. This would be advantageous 
if one has low levels of HMG-CoA reductase activity. This procedure 
separates all of the products and an investigation is able to determine 
the products without worrying about losing radioactivity by extraction 
procedures. 
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2. HMG-CoA Reductase Activity from N. Cataria 
Fresh N. cataria leaf tissue (60 g) was used for this experiment. 
The cell-free extract was obtained as described irt methods. The puri-
fication procedure described in Figure 2 was used, with the final step 
being the 20-45% sucrose gradient. 
Table V indicates that the bulk of the HMG-CoA reductase activity 
occurs in the 30-70% ammonium sulfate precipitate (Figure 28). When 
the 30-70% pellet was applied to a 20-45% discontinuous sucrose gradi-
ent, two activities are observed on the sucrose gradient (Figure 29). 
This is similar to the data one observes for mevalonate kinase activity. 
However, the second activity of HMG-CoA reductase and mevalonate kinase 
do not overlap. 
3. HMG-CoA Reductase Activity in Chloroplasts 
Chloroplasts were isolated from_!. cataria leaf tissue in similar 
manner as described for mevalonate kinase. The chloroplasts (9.8 mg/ml) 
were resuspended in 1.0 ml of 100 mM Tris pH 7.5, 1.0 mM EDTA, 1.0 mM 
dithiothreitol and homogenized. The homogenized chloroplasts were 
placed on a 20-45% discontinuous sucrose gradient and centrifuged at 
20,000 x g for three hours. Five fractions of six ml each were col-
lected and assayed for HMG-CoA reductase activity. Only one peak 
HMG-CoA reductase activity was observed - that being in fraction four 
as shown in Figure 30. This activity corresponds to the second 
activity observed with the 30-70% ammonium sulfate precipitate of the 
whole leaf was centrifuged in a 20-45% discontinuous sucrose gradient. 
TABLE V 
PARTIAL PURIFICATION OF HMG-CoA REDUCTASE 
Step Volume Concentration Total Protein Specific(a) Yield Purification 
ml Units/ml Units Mg/ml Activity 
1) Crude Homogenate 60 274 16.440 19.1 .014 100.0% 1.00 
3,000 x g Supernatant 56 271 15,176 16.2 .017 92.0% 1.17 
30,000 x g Supernatant 53 269 14,257 15.0 .018 87.0% 1.25 
30, 000 x g Pellet 3.1 60 186 4.6 .013 1.1% 0.91 
2) Ammonium Sulfate Fractionation - - - - -
30% Supernatant 48 260 12,480 8.8 .030 76.0% 2.06 
30% Pellet 4.6 29.8 137 4.3 .007 0.8% 0.48 
70% Supernatant 45 8.9 401 5.7 .002 0 3.45 
70% Pellet 9.6 890 8,544 7.8 .050 52.0 
3) Sucrose Gradients of 70% Pellet - - -
Fraction 1 30 72.6 2,187 1.25 .058 13.2 4.05 
Fraction 2 30 10.3 309 .60 .017 1.4 1.20 
Fraction 3 30 18.1 543 . 44 .041 3.3 2.87 
Fraction 4 30 57.1 1, 713 .31 .084 10.4 12.84 
Fraction 5 30 34.5 1,035 .79 .044 6.3 3.05 
(a) Specific Activity Units are given in nanomoles of mevalonate formation min - 1 mg - 1 of protein 
\.0 
I-' 
Figure 28. Dowex-1 Formate Elution Pattern: HMG-CoA Reductase Assay 
of 30 to 70 Percent Annnonium Sulfate Precipitate from 
Leaf Tissue 
Elution profile following assay for HMG-CoA reductase of 
leaf 30 to 70 percent ammonium sulfate precipitate under 
standard assay conditions. Elution of Dowex-1 column: 
AG. Linear gradient of 0-2 N formic acid using three 
chambers containing 50 ml water, 50 ml 1 N formic 
acid and 50 ml 2 N formic acid 
c. 50 ml of 4 N formic acid 
D. 50 ml of 4 N formic acid + 0.4 N ammonium formate 
E. 50 ml of 4 N formic acid + 0.8 N ammonium formate 
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Figure 29. Protein and HMG-CoA Reductase Activity Profile from 20 to 
45 Percent Sucrose Gradient Centrifugation of 30 to 70 
Percent Ammonium Sulfate Precipitate from Leaf Tissue 
Protein (---), HMG-CoA Reductase (~) 
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Figure 30. Protein and HMG-CoA Reductase Activity Profile from 20 to 
45 Percent Sucrose Gradient Centrifugation of Homogenized 
Chloroplasts 
Protein (---), HMG-CoA Reductase (~) 
"'j .6 
Cl 
E 
I 
c 
E 
"C 
Q) 
E 
.... 
0 
...... 
~ 
~ 
(/J 
Q) 
0 
E 
c 
.3 
I 
., 
I 
2.0 
I 
I 
)···· 
. ... I 
.. I 0 . .. . 
r, .. ·· 
.. 
.. • 
/~ .. '< ... , 
I '·- - -I 
2 3 
FRACTION 
I 
I 
I 
4 
I 
5 
97 
...J 
:E 
' <!) ~ 
45 °/o 
z Q) 
LJ.J (/J 
I- o~ 
0 t;o 
a:: :::J 
0.. en 
20°/o 
98 
4. Kinetic Studies 
Fraction four from the sucrose gradient of the homogenized 
chloroplasts was dialyzed against 100 mM Tris pH 7.5 and 1.0 mM 
dithiothreitol and concentrated to 1.5 ml on diaflow membrane apparatus. 
The concentrated fraction four had a concentration of 1.54 mg/ml and 
184.1 units/mg and was purified 12.8 fold. 
Stock solutions of HMG-CoA were mixed with 3- 14 C-HMG-CoA to give 
specific activities of 0.51, 1.01, 3.77, 5.03, 9.14, 11.97, 15.08 
micromoles per microcurie. Assays were incubated in a total volume of 
1.0 ml at 37 C for 30 minutes. The incubation mixture of 100 mM Tris 
pH 7.5, 1.0 mM EDTA, 1.0 mM dithiothreitol, 10.0 mM glucose-6-phosphate 
dehydrogenase and the enzyme source was preincubated for 10 minutes to 
allow for the formation of NADPH. The reaction was started by the 
addition of the labelled substrate HMG-CoA in various amounts. The 
reaction was terminated by freezing in dry ice/acetone. The mevalonate 
formed was then converted to mevalonolactone by the addition of 200 µl 
of 2 !'!. H2S04 and allowing it to stand at room temperature for 10 
minutes. The reaction mixture was lyophilyzed, extracted with ether, 
evaporated to dryness and resuspended as described in methods. The 
resuspended extract was applied to Dowex-1 formate column and eluted 
with 5 ml of water to remove the mevalonolactone. The eluent was 
collected as one five ml fraction and 10 ml of Insta-gel was added and 
counted with a scintillation counter. Velocity of the reaction was 
determined by calculating the number of nmoles of mevalonate lactone 
formed per minute. The results are presented as a Lineweaver-Burk 
plot in Figure 31. 
Figure 31. Lineweaver-Burk Plot of l/Velocity vs. l/HMG-CoA Reductase 
The assay system utilized was the standard system except 
for varying concentrations of HMG-CoA. 
> 
......... 
20 
60 
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100 
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The plot is a best-fit line to the data as obtained from a least 
square analysis. 
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The apparent Km for HMG-CoA as calculated from the Lineweaver-Burk 
plot shown in Figure 30 is 113 µM. 
5. HMG-CoA Reductase in Turkey 
Cell-free extracts from quick frozen turkey kidney tissue were 
obtained by homogenizing 100 grams of tissue in a blender with 100 ml 
of buffer. (Buffer was the same as the buffer described in Preparation 
of Cell-Free Extracts with the exception that 50 mM sucrose was used.) 
The crude supernatant was assayed by separating the products on a 
Dowex-1 formate ionexchange column with a gradient elution. The 
product mevalonate was formed as well as a small unknown peak. Figure 
28 gives product profile of th~ crude supernatant. 
Cell-free extracts from turkey kidney were subjected to the pro-
cedure described in Figure 3. The HMG-CoA reductase activity was 
found to be in the 30-70% ammonium sulfate precipitate. The precipi-
tate was resuspended in 3 ml of 100 mM Tris pH 7.5, 1.0 mM EDTA, 0.5 
mM dithiothreitol, 0.1 mM mevalonate to give a total volume of 6 ml. 
The resuspended pellet was divided into two 3 ml fractions and one 
portion was dialyzed against 10 mM Tris pH 7.5, 0.5 mM dithiothreitol. 
The dialyzed fractions were assayed for HMG-CoA reductase activity as 
described in methods. Figures 32 and 33 show the effect of assaying 
in the presence of 0.1 mM mevalonate and without mevalonate. Without 
mevalonate a peak appears that elutes off a Dowex-1 formate column at 
a very low ionic strength. This peak is only slightly detectable in 
the presence of mevalonate. In the presence of 0.1 mM mevalonate 1.5 
Figure 32. Dowex-1 Formate Elution Pattern: Crude Homogenate HMG-CoA 
Reductase Assay of Turkey Kidney 
Elution profile following assay for HMG-CoA reductase of 
turkey kidney crude homogenate under standard assay con-
ditions. Elution of Dowex-1 column: 
AG. Linear gradient of 0-2 N formic acid using three 
chambers containing 50 ml water, 50 ml 1 N formic 
acid and 50 ml 2 N formic acid 
c. 50 ml of 4 N formic acid 
D. 50 ml of 4 N formic acid + 0.4 N ammonium formate 
E. 50 ml of 4 N formic acid + 0.8 N ammonium formate 
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Figure 33. Dowex-1 Formate Pattern: HMG-CoA Reductase Assay of 30 to 
70 Percent Ammonium Sulfate Precipitate from Turkey 
Kidney in the Presence of 0.1 mM Mevalonate 
Elution profiles following assay of turkey kidney 30 to 
70 percent annnonium sulfate precipitate in the presence 
of 0.1 mM mevalonate (A) and with no mevalonate present 
(B) and-a-11 other assay conditions standard. Elution of 
Dowex-1 column: 
AG. Linear gradient of 0-2 ~ formic acid using three 
chambers containing 50 ml water, 50 ml 1 N formic 
acid and 50 ml 2 N formic acid 
c. 50 ml of 4 N formic acid 
D. 50 ml of 4 N formic acid + 0.4 N ammonium formate 
E. 50 ml of 4 N formic acid + O. 8 N ammonium formate 
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nmoles of mevalonate were formed, without mevalonate present 1.57 
nmoles of mevalonate were formed. There is apparently very little 
effect by the product at the level used in this study. One ml of the 
70% pellet dialyzed against 0.1 mM mevalonate was placed on a 30 ml 
20-45% sucrose gradient as described for the mevalonate kinase isolated 
from N. cataria. Five fractions of six ml each were collected and 
dialyzed against the same buffer used in the previous dialysis. 
The dialyzed fractions were then assayed for HMG-CoA reductase as 
described for the 70% pellet. The first fraction was the only fraction 
that showed activity. Figure 34 shows the product profile of this 
fraction. The specific activity of HMG-CoA reductase in this fraction 
was 261 pmoles/mg min as compared to a specific activity of 46.0 
pmoles/mg min for the cell-free extract. This indicates a purification 
of 5.67 fold. 
Figure 34. Dowex-1 Formate Elution Pattern: HMG-CoA Reductase Assay 
of Fraction One of 20 to 45 Percent Sucrose Gradient of 
30 to 70 Percent Ammonium Sulfate Precipitate from 
Turkey Kidney 
Elution profile following assay for HMG-CoA reductase 
of turkey kidney fraction one of 20 to 45 Percent dis-
continuous sucrose gradient under standard assay 
conditions. Elution of Dowex-1 column: 
AG. Linear gradient of 0-2 N formic acid using three 
chambers containing 50 ml water, 50 ml 1 N formic 
acid and 50 ml 2 N formic acid 
C. 50 ml of 4 N formic acid 
D. 50 ml of 4 N formic acid + 0.4 N ammonium formate 
E. 50 ml of 4 N formic acid + 0.8 N ammonium formate 
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CHAPTER V 
SUMMARY 
The mevalonate activating enzymes mevalonate kinase, 5-phospho-
mevalonate kinase and 5-pyrophosphomevalonate decarboxylase co-purify 
through 30 to 70 percent ammonium sulfate precipitate, 20 to 45 percent 
discontinuous sucrose gradient, and Bio-Gel P-100 column, suggesting 
that the molecular weight of the individual enzymes of mevalonate 
activating system or the enzyme complex is in excess of 100,000 daltons. 
In N. cataria leaf tissue mevalonase kinase and 5-phosphomevalonate 
kinase were found to be present in both the light microsomal membrane 
fraction and in the chloroplasts. Callus tissue from N. cataria was 
found to contain only one mevalonate activating system which corresponds 
to the extra-chloroplastidic enzyme system. The callus tissue did not 
contain chloroplasts. Turkey liver and kidney, hog liver and yeast 
autolysates were all shown to have only one system. 
Another interesting note that gives support to the possibility 
that the mevalonate activating enzymes may be a complex in N. cataria 
leaf tissue is the fact that the ratio of the products 5-phospho-
mevalonate and 5-pyrophosphomevalonate in the microsomal system remains 
constant throughout purification from the 30 to 70 percent ammonium 
sulfate precipitate through the P-100 column. The mammalian systems 
showed wide variation in the ratio of these two products, which is 
characteristic of non-associated enzymes. 
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In N. cataria leaf tissue two activities of HMG-CoA reductase were 
also observed with one activity being localized in the chloroplasts. 
The chloroplastidic HMG-CoA reductase exhibited a Km for HMG-CoA of 
113 µM. The chloroplastidic HMG-CoA reductase could be separated from 
the chloroplastidic mevalonate kinase by the use of a sucrose density 
gradient. However, the extra-chloroplastidic (microsomal membrane) 
HMG-CoA reductase and mevalonate kinase activities both appear in the 
first fraction of the 20 to 45 percent sucrose gradient. HMG-CoA 
reductase from turkey kidney showed only one activity profile which 
was located at the top of the 20-45% sucrose density gradient. 
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